About Aditi Ganguly
Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do's and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities.
Aditi's fascination with the stock market began in college, where she majored in Economics, while researching The Great Recession for her thesis. After graduating, she began her career handling the content requirements for the mutual fund aggregator Groww. Since then she has become a financial journalist that focuses on writing articles that educate retail investors about the equity markets and the global economy.
Recent Articles By Aditi Ganguly
Is Albertsons a Good Value Stock to Add to Your Portfolio?
Albertsons Companies (ACI) is one of the oldest names in the grocery retail industry, with more than eight decades of experience. After administering an IPO last June, its stock has been trading at a discount to its peers. But will the stock generate momentum with investors now rotating away from the pricey retail space toward turnaround industries such as restaurants, transportation etc.? Read more to find out.
Is Universal Health Services a Great Value Stock to Own Right Now?
Through mass vaccination drives and social distancing regimes, after a grueling year the United States is finally making some headway in reducing COVID-19 contagion. But as the public health emergency comes under control, will the shares of international hospital chain operator Universal Health Services (UHS)—which are trading at a discount—move higher? Read on to find out.
QAD Inc.: An Under the Radar Tech Stock with Massive Growth Potential
Budding cloud computing company QAD Inc. (QADA) has been expanding rapidly to increase its product and services pipeline and branch out to markets with substantial demand. We believe these moves should help the company to gradually become a leading player in the booming cloud markets, accelerating its revenue and earnings growth in the near future. Let’s look closer.
2 Health Care Stocks Under $5 to Buy Now: BioDelivery Sciences and Global Cord Blood
The healthcare industry in the United States is expected to become more affordable and innovation-oriented post COVID-19 pandemic, owing to shifting strategies by biopharma companies and the government. We believe relatively lesser known and lower-priced companies, for example Global Cord Blood (CO) and BioDelivery Sciences (BDSI), that have portfolio pipelines of disruptive products and services, should witness substantially higher gains versus their more well-known and high-priced counterparts. Let’s discuss.
VMware: Buy or Sell?
VMware (VMW) is expected to be spun off from its parent Dell (DELL) after September this year. Given its dominating market position, the company should reach its true growth potential and valuation following the spin-off, as it is currently affected by DELL’s complex capital structure. Thus, we expect VMW to reach fresh highs in the second half of this year.
Align Technology: A Stock to Sink Your Teeth Into
Dental health device manufacturer Align Technology (ALGN) has been on a growth streak over the past year and its stock delivered triple-digit returns. The company demonstrated business resilience during the pandemic, and is currently surging as people return to the dentist and orthodontist. With solid fundamentals and financial strength, ALGN is expected to maintain its growth trajectory in the near term.
Is Stryker a Winner in the Medical Device Industry?
Medical device manufacturer Stryker (SYK) last year showed operational resilience amid the COVID-19 pandemic despite depressed demand levels. However, as the global economy returns to pre-pandemic levels, the medical devices industry is expected to undergo a structural change to better equip itself to deal with medical crises. The question then is will SYK be able to make these changes to retain its foothold in a rebounding medical devices industry? Read more to find out.
Is Anthem a Good Health Insurance Stock to Own in 2021?
Severely affected by the coronavirus pandemic disruption and macroeconomic headwinds, the price of Anthem (ANTM) stock declined significantly over the past year. However, as the economy recovers, rising per-capita income and consumer spending is expected to drive up the demand for health insurance, particularly relating to COVID-19 and its side effects. This, coupled with ANTM’s internal policies, should, we believe, allow the stock to hit fresh highs in 2021.
2 Cybersecurity Stocks to Consider Buying in 2021
The recent cyberattack on the U.S. government, deemed to be the worst cyberattack in history, has increased awareness regarding cybersecurity. With most workplaces adopting hybrid working models, the demand for integrated cybersecurity technologies should rise this year. We think this should benefit budding cybersecurity stocks McAfee (MCFE) and Check Point Software Technologies (CHKP). Let’s discuss.